Operating Expenses

Impairment of Intangible Assets (Excl. Goodwill)

Amgen Impairment of Intangible Assets (Excl. Goodwill) decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $800.00M to $0.00.

Analysis

StatementIncome Statement
SectionOperating Expenses
First reportedQ1 2023
Last reportedQ1 2026Apr 30, 2026
Metric ID: pfe_impairment_of_intangible_assets_excluding_goodwill

Historical Data

11 periods
 Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q3 '25Q1 '26
Value$212.75M$212.75M$212.75M$212.75M$68.00M$0.00$61.00M$30.00M$800.00M$400.00M$0.00
QoQ Change+0.0%+0.0%+0.0%-68.0%-100.0%-50.8%>999%-50.0%-100.0%
YoY Change-68.0%-100.0%-71.3%-85.9%>999%+555.7%-100.0%
Range$0.00$800.00M
CAGR-100.0%
Avg YoY Growth+172.4%
Median YoY Growth-71.3%
Current Streak2 quarters decline

Frequently Asked Questions

What is Amgen's impairment of intangible assets (excl. goodwill)?
Amgen (AMGN) reported impairment of intangible assets (excl. goodwill) of $0.00 in Q1 2026.
How has Amgen's impairment of intangible assets (excl. goodwill) changed year-over-year?
Amgen's impairment of intangible assets (excl. goodwill) decreased by 100.0% year-over-year, from $800.00M to $0.00.